Market Closed -
Other stock markets
|
|
5-day change | 1st Jan Change | |
1.08 SGD | +0.93% | +5.88% | -22.86% |
09:50am | Raffles Medical Buys Back Shares | MT |
Dec. 07 | Raffles Medical Buys Back Shares | MT |
Sales 2023 * | 712M 532M | Sales 2024 * | 712M 532M | Capitalization | 1.99B 1.48B |
---|---|---|---|---|---|
Net income 2023 * | 94M 70.23M | Net income 2024 * | 91M 67.99M | EV / Sales 2023 * | 2,46x |
Net cash position 2023 * | 234M 175M | Net cash position 2024 * | 280M 209M | EV / Sales 2024 * | 2,40x |
P/E ratio 2023 * | 21,1x | P/E ratio 2024 * | 21,8x | Employees | 2,800 |
Yield 2023 * | 3,05% | Yield 2024 * | 3,06% | Free-Float | 43.75% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
1 day | +0.93% | ||
1 week | +2.86% | ||
Current month | +5.88% | ||
1 month | +4.85% | ||
3 months | -12.90% | ||
6 months | -18.18% | ||
Current year | -22.86% |
1 week
1.04
1.10

1 month
1.02
1.10

Current year
1.01
1.52

1 year
1.01
1.52

3 years
0.86
1.58

5 years
0.73
1.58

10 years
0.73
1.68

Managers | Title | Age | Since |
---|---|---|---|
Alfred Loh
FOU | Founder | - | 1975 |
Director of Finance/CFO | 57 | 2020 | |
Wong Wilson
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Choon Yong Loo
FOU | Founder | 73 | 1975 |
Soo Nan Tan
BRD | Director/Board Member | 75 | 2000 |
Teik Siew Ang
BRD | Director/Board Member | 70 | 2015 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.47% | 19 M€ | -.--% | ||
0.47% | 14 M€ | +3.65% | - | |
0.29% | 36 M€ | +1.69% | ||
0.17% | 3 M€ | 0.00% | - | |
0.11% | 56 M€ | +10.06% | - |
Date | Price | Change | Volume |
---|---|---|---|
23-12-08 | 1.08 | +0.93% | 1 112 500 |
23-12-07 | 1.07 | -1.83% | 1,643,800 |
23-12-06 | 1.09 | +2.83% | 6,534,900 |
23-12-05 | 1.06 | 0.00% | 1,237,700 |
23-12-04 | 1.06 | +0.95% | 1,205,300 |
Delayed Quote Singapore Stock Exchange, December 08, 2023 at 04:04 am EST
More quotes
Raffles Medical Group Ltd is a Singapore-based integrated private healthcare provider. The principal activities of the Company are those relating to the operation of medical clinics, other general medical services, and investment holdings. The Company's segments include Healthcare Services, Hospital Services, and Investment Holdings. The Healthcare Services segment is engaged in the operations of medical clinics and other general medical services; provision of health insurance, trading in pharmaceutical and nutraceutical products and diagnostic equipment, and provision of management and consultancy services. The Hospital Services segment is engaged in the provision of specialized medical services and operation of hospital and business of medical laboratory and imaging center. The Investment Holdings segment is engaged in investment holding and those relating to investment properties. It operates medical facilities in about 14 cities in Singapore, China, Japan, Vietnam, and Cambodia.
Calendar
2024-02-25
- Q4 2023 Earnings Release (Projected)
Trading Rating :
Investor Rating :
ESG Refinitiv :
C+
Sell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
1.07SGD
Average target price
1.292SGD
Spread / Average Target
+20.79%